News

TNF Inhibitors Don't Boost Zoster Risk

Publish date: February 16, 2012

 

EXPERT ANALYSIS FROM A SYMPOSIUM SPONSORED BY THE AMERICAN COLLEGE OF RHEUMATOLOGY

Dr. Winthrop reported having no financial conflicts.

Pages

Recommended Reading

Breast Cancer Drug Exemestane Linked to BMD Loss
MDedge Internal Medicine
Surgery Brings Big Benefits in Lumbar Stenosis
MDedge Internal Medicine
Intra-Articular Glucocorticoids Controlled Early RA
MDedge Internal Medicine
Spot Lumbar Spinal Stenosis From Across the Room
MDedge Internal Medicine
FDA Issues Guidelines on Developing Biosimilar Products
MDedge Internal Medicine
Obesity Epidemic Is Skewing Face of Gout
MDedge Internal Medicine
Physicians Often Missing Boat on Gout Therapy
MDedge Internal Medicine
Anticipate Mycobacterial Lung Disease in Anti-TNF Users
MDedge Internal Medicine
New Insights Gained Into Biologics' Infection Risk
MDedge Internal Medicine
MRI Inflammation 'Marginally' Predicts AS Bone Growth
MDedge Internal Medicine